Oxadiazole scaffolds in anti-tuberculosis drug discovery

[Display omitted] With the increasing number of cases of latent and drug resistant tuberculosis, there is an urgent need to develop new, potent molecules capable of combating this deadly disease. Molecules containing oxadiazoles are one such class that could be considered to fulfil this need. Oxadia...

Full description

Saved in:

Bibliographic Details
Published in:	Bioorganic & medicinal chemistry letters Vol. 29; no. 16; pp. 1999 - 2007
Main Authors:	De, Suparna S., Khambete, Mihir P., Degani, Mariam S.
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 15-08-2019
Subjects:	Bioisoster Linker Oxadiazole Regioisomer Tuberculosis Oxadiazole Tuberculosis Bioisoster Linker Regioisomer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[Display omitted] With the increasing number of cases of latent and drug resistant tuberculosis, there is an urgent need to develop new, potent molecules capable of combating this deadly disease. Molecules containing oxadiazoles are one such class that could be considered to fulfil this need. Oxadiazole regioisomers have been explored in drug discovery programs for their ability to act as effective linkers and also as pharmacophoric features. Oxadiazoles can act as bioisosteric replacements for the hydrazide moiety which can be found in first line anti-TB drugs, and some have been also reported to interact with newer anti-TB targets. In this context, the present review describes the potential of oxadiazoles as antituberculosis agents.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	0960-894X 1464-3405
DOI:	10.1016/j.bmcl.2019.06.054